INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 14 filers reported holding INNATE PHARMA S A in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $118,842 | -23.5% | 46,973 | -5.0% | 0.00% | – |
| Q2 2023 | $155,273 | +88123.3% | 49,450 | -20.1% | 0.00% | – |
| Q1 2023 | $176 | -34.1% | 61,899 | -13.7% | 0.00% | – |
| Q4 2022 | $267 | -99.1% | 71,684 | +389.8% | 0.00% | – |
| Q3 2022 | $29,000 | -37.0% | 14,634 | -13.2% | 0.00% | – |
| Q2 2022 | $46,000 | -45.2% | 16,856 | -32.9% | 0.00% | – |
| Q1 2022 | $84,000 | -66.7% | 25,115 | -54.4% | 0.00% | – |
| Q4 2021 | $252,000 | +50.9% | 55,021 | +102.9% | 0.00% | – |
| Q3 2021 | $167,000 | +7.7% | 27,118 | -42.0% | 0.00% | – |
| Q2 2021 | $155,000 | -27.6% | 46,767 | -6.0% | 0.00% | – |
| Q1 2021 | $214,000 | -4.5% | 49,734 | -9.1% | 0.00% | – |
| Q4 2020 | $224,000 | -22.2% | 54,697 | -24.7% | 0.00% | – |
| Q3 2020 | $288,000 | -45.7% | 72,657 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $530,000 | +9.3% | 72,657 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $485,000 | +1.7% | 72,657 | -2.1% | 0.00% | 0.0% |
| Q4 2019 | $477,000 | – | 74,242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Optiver Holding B.V. | 181,944 | $491,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 175,229 | $473,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 16,856 | $46,000 | 0.00% |
| CREDIT SUISSE AG/ | 1,981 | $5,000 | 0.00% |
| CITIGROUP INC | 55 | $0 | 0.00% |
| MORGAN STANLEY | 46,598 | $126,000 | 0.00% |
| BlackRock Inc. | 497,275 | $1,343,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 905 | $2,000 | 0.00% |
| Steward Partners Investment Advisory, LLC | 500 | $1,000 | 0.00% |